Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- CREST-2, CREST-H: Revascularization Does Not Improve Cognition in Asymptomatic Carotid StenosisFor patients with severe asymptomatic carotid artery stenosis, adding revascularization with either carotid artery stenting (CAS) or carotid endarterectomy (CEA) to intensive medical management (IMM) did not improve cognition compared with IMM alone...
- ATTR-CM: Concomitant Therapy and Vutrisiran Treatment Effect; New Disease Progression FrameworkConcomitant use of tafamidis or heart failure (HF) therapies did not modify the treatment benefit of vutrisiran on all-cause mortality and recurrent cardiovascular events, according to a HELIOS-B analysis recently published in JACC.
- Eagle’s Eye View: Can Extreme Heat Impact Blood Pressure?In this week’s View, Dr. Eagle looks at a recent JACC: Advances Viewpoint that examines the challenges associated with implementing revisions to the definition of first medical contact (FMC) introduced in the 2025 ACC/AHA ACS Guideline and its implications for NCDR data collection.
- Beyond the Tumor: Dyslipidemia Management in Patients With and Survivors of CancerASCVD prevention has historically targeted the general adult population, with survivors of cancer and patients with active cancer being underrepresented. Cancer and its therapies may increase cardiovascular (CV) risk and accelerate vascular disease through treatment-related dyslipidemia...
- ACCEL Lite: Antithrombotic Therapy After TAVIIn this episode, Deepak L. Bhatt MD, MPH, MBA, FACC and Øyvind H. Lie, MD, PhD, MSc examine the results of “ACASA-TAVI: Antithrombotic therapy after TAVIâ€.



